Who makes B dose as CJ-15314?

B dose as CJ-15314 is developed by HK inno.N Corporation.

What development phase is B dose as CJ-15314 in?

B dose as CJ-15314 is in Phase 1.

Last reviewed 2026-04-20 · How we verify

B dose as CJ-15314

HK inno.N Corporation · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	B dose as CJ-15314
Sponsor	HK inno.N Corporation
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

B dose as CJ-15314 CI brief — competitive landscape report
B dose as CJ-15314 updates RSS · CI watch RSS
HK inno.N Corporation portfolio CI